Introduction
============

The use of electricity to manage human ailments is an age-old concept that dates back to 2500 BC when ancient Egyptians used electric fish to produce "shocks" to relieve pain.[@b1-prom-5-035] During the 19th century, the use of electricity in medicine gained popularity with the development of a variety of electromedical devices. From the mid-1960s, the pioneering works of Melzack and Wall,[@b2-prom-5-035] Shealy et al,[@b3-prom-5-035] Reynolds,[@b4-prom-5-035] and Long[@b5-prom-5-035] led to further developments in electroanalgesic techniques, resulting in the introduction of transcutaneous electrical nerve stimulation (TENS) into mainstream medicine.

TENS is a noninvasive, inexpensive, self-administered medical technique used throughout the world to relieve pain.[@b6-prom-5-035] The purpose of TENS is to excite low-threshold peripheral afferent nerve fibers that convey neural information related to non-noxious stimuli to the brain, as this has been shown to close the "pain gate" and relieve pain.[@b7-prom-5-035] During TENS, pulsed currents of varying amplitude, duration, and frequency are generated by a portable battery-operated device and delivered via lead wires to electrodes attached to the intact surface of skin ([Figure 1](#f1-prom-5-035){ref-type="fig"}). The electrodes may be self-adhesive or smeared with conducting gel and secured using touch fastener straps or medical tape. The electrical characteristics of TENS can be adjusted by the user and dosage titrated according to need whenever the individual is experiencing pain. For most patients, pain relief during TENS is rapid in onset and associated with few adverse effects or drug interactions.[@b6-prom-5-035]--[@b8-prom-5-035] Systematic reviews and meta-analyses of randomized controlled clinical trials provide evidence that TENS is effective for relief of many types of pain, including musculoskeletal[@b9-prom-5-035] and postsurgical pain.[@b10-prom-5-035] Some systematic reviews have failed to find efficacy[@b11-prom-5-035] or have been inconclusive.[@b12-prom-5-035] This has been attributed to methodological shortcomings in randomized controlled clinical trials, including the use of inappropriate TENS technique leading to underdosing.[@b13-prom-5-035],[@b14-prom-5-035] In general, it is believed that TENS should be used as a standalone treatment for mild-to-moderate pain and as an adjunct to pharmacotherapy for moderate-to-severe pain.[@b7-prom-5-035],[@b8-prom-5-035] TENS has also been used in the management of dementia,[@b15-prom-5-035] postoperative nausea and vomiting,[@b16-prom-5-035] and wound healing.[@b17-prom-5-035]

A recent systematic review revealed that the prevalence of chronic pain worldwide is high -- over 25%.[@b18-prom-5-035] There were insufficient reliable data by which to estimate with any certainty the prevalence of chronic pain in resource-limited countries with a Human Development Index (HDI) of less than 0.9, although prevalence appeared to be similar to that seen worldwide.[@b18-prom-5-035] The prevalence of chronic pain in Sri Lanka has not been established. Census data from 2012 found that the national population was 20,263,723 (<http://www.statistics.gov.lk/PopHouSat/CPH2012Visualization/htdocs/index.php?usecase=indicator&action=Map&indId=10>),[@b19-prom-5-035] so approximately 5.08 million people may be experiencing chronic pain at any one time if prevalence is taken as 25%. This burden of pain is likely to have a major impact on national health care costs.[@b20-prom-5-035]--[@b22-prom-5-035] Pharmacotherapy remains the mainstay treatment for painful conditions in developing countries including Sri Lanka, although analgesic medication may cause significant adverse effects and access to opioid medication is a problem.[@b23-prom-5-035] The financial costs of pharmacotherapy can be high, especially if patients are prescribed analgesics for prolonged lengths of time.[@b23-prom-5-035] For these reasons, good practice guidelines for pain management recommend nonpharmacological alternatives as adjuncts for the management of chronic pain.

In Sri Lanka, physicians, physiotherapists, nurses, and midwives may recommend the use of TENS to their patients. A TENS device and associated accessories are available without prescription and can be bought at pharmacy outlets or via the internet for approximately 20,000 Sri Lankan rupees. All physiotherapists receive a small amount of education about the principles and practice of TENS in their undergraduate training or during clinical practice. To date, there have been no data gathered about the use of TENS by physiotherapists in Sri Lanka. Therefore, the aim of this postal survey was to assess attitudes and beliefs of physiotherapists working in Sri Lanka about their use of TENS for pain management.

Methods
=======

The study was approved by the ethical review committee, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. The postal survey was conducted throughout August and September 2012 on physiotherapists working in departments of physical medicine in government and private hospitals in two major Sri Lankan cities -- Kandy and Colombo. At the time of the survey there were two government and two private hospitals with physiotherapy departments in Kandy, and two government and eleven private hospitals with physiotherapy departments in Colombo. Attempts were made to contact all physiotherapy departments to invite them to take part in the survey. Three government hospital departments (two in Kandy) and six private hospital departments (two in Kandy, four in Colombo) agreed to take part. The principal investigator (TDD) delivered, in person, a "survey pack" to each physiotherapy department.

The survey pack consisted of a participant information sheet, a formal invitation letter, and a survey questionnaire, and was given to all members of the physiotherapy team who managed mixed caseloads of "pain patients". The paper-based questionnaire consisted of 12 items and was designed by two members of the investigating team (GB, MIJ) and previously used on a population of Indian physiotherapists working in city hospitals in India.[@b24-prom-5-035] The questionnaire gathered information about the attitudes and beliefs of physiotherapists about their use of TENS and its role in pain management.

After 1 month, completed questionnaires were collected by departmental chief physiotherapists and sent via post to the principal investigator. Questionnaires were coded to maintain anonymity, although the location of the physiotherapy department was documented. A descriptive analysis was performed with data presented as counts and percentage responses to each question. It was decided not to conduct inferential statistics because of the relatively small sample size. SPSS v 17 (SPSS Inc., Chicago, IL, USA) was used to manage data and conduct the analysis.

Results
=======

One hundred physiotherapists were given survey packs, and 67 completed questionnaires were returned (67% response rate). Sixty of the 67 (89.5%) respondents were registered physiotherapists, with seven of the 67 (10.4%) respondents having their registration under renewal or pending (question \[Q\]12).

Of these 67 respondents, 64 (95.5%) reported that they treated pain "very often" (n=31) or "often" (n=33) in their clinical practice (Q1). Three respondents reported that they treated pain "occasionally". Thirty-nine (58.2%) of these respondents reported that they used TENS to treat pain "often" (n=32) or "very often" (n=7) (Q2). Twenty-seven (40.3%) respondents reported that they used TENS to treat pain "occasionally" and one respondent reported that they used TENS "seldom".

For the management of acute pain, 55.2% of respondents reported that they used TENS "often" or "very often", and 25.4% reported that they did not use TENS "at all" ([Table 1](#t1-prom-5-035){ref-type="table"} \[Q3a\]). For the management of subacute pain, 61.2% of respondents reported that they used TENS "often" or "very often", and only 6.0% reported that they did not use TENS "at all". For the management of chronic pain, 55.2% of respondents reported that they used TENS "often" or "very often", and the percentage of respondents reporting not "at all" was zero.

Only 65 respondents provided answers for questions related to the severity of pain (Q3b). A larger proportion of respondents reported that they used TENS "very often" or "often" for pains that were more severe. For example, 23.1% of respondents reported that they used TENS "very often" or "often" for the management of mild pain, compared with 70.8% for the management of severe pain ([Table 1](#t1-prom-5-035){ref-type="table"}). Only 12.3% of respondents reported that they did not use TENS "at all" for severe pain, compared with 29.2% for mild pain.

Respondents reported that they used TENS "very often" or "often" for pain associated with musculoskeletal/orthopedics conditions (61.3%) or neuropathies/neuralgias (79.1%) ([Table 1](#t1-prom-5-035){ref-type="table"} \[Q4\]). Only 10.45% and 6.0% of respondents reported that they did not use TENS "at all" for musculoskeletal/orthopedic or neuropathic/neuralgia pain respectively. Fewer respondents reported that they used TENS "very often" or "often" for pain associated with postsurgical conditions (20.9%) or cancer pain (1.5%). Forty-seven (70.1%) respondents reported that they that they did not use TENS "at all" for pain associated with cancer.

Sixty-four (95.5%) respondents reported that their patients benefitted "considerably" from TENS, with two respondents reporting "No improvement noticed" (Q5). Fifty-one respondents (76.1%) reported that they did not recommend/prescribe TENS for patients to use at home, suggesting that patients needed to make clinic visits to receive TENS treatment ([Figure 2](#f2-prom-5-035){ref-type="fig"} \[Q6\]).

Twenty-seven (40.3%) respondents reported that referring physicians had "never" recommended that the physiotherapist use TENS for pain relief ([Figure 3](#f3-prom-5-035){ref-type="fig"} \[Q7\]), and 47.7% of respondents reported that their patients had requested TENS treatment from them (Q8).

Twenty-five respondents (37.3%) reported that their patients had used TENS before they came to receive pain treatment (Q9), and 44.8% of respondents reported that they believed that TENS was a cost-effective treatment option ([Figure 4](#f4-prom-5-035){ref-type="fig"} \[Q10\]). Sixty-two respondents (92.5%) reported that they also used TENS-like devices, including interferential therapy, to manage pain (Q11).

Discussion
==========

This questionnaire survey of physiotherapists in two major cities in Sri Lanka found that 58.2% of respondents reported that they used TENS to treat pain "very often" or "often", although over 95% reported that they believed that TENS was "considerably" beneficial. It was found that respondents reported that they often used TENS for neurological and musculoskeletal pain, but only "occasionally" for postsurgical pain and "seldom" for cancer pain. This pattern of use is similar to that seen in Australia, Europe, and USA, and is likely to reflect patient presentation patterns and beliefs of therapists about effectiveness of TENS for these conditions.[@b8-prom-5-035],[@b25-prom-5-035],[@b26-prom-5-035] Evidence from systematic reviews suggests that TENS is effective for chronic musculoskeletal pain,[@b9-prom-5-035] neuropathic pains,[@b26-prom-5-035],[@b27-prom-5-035] and postsurgical pain.[@b10-prom-5-035],[@b28-prom-5-035] Evidence for effectiveness for cancer pain is limited but promising.[@b29-prom-5-035]

A main finding of the survey was that over 76.1% of respondents reported that they did not recommend that TENS should be used at home. Thus, patients would need to visit the clinic in order for each TENS treatment session. This is costly in staff time and inconvenient for the patient. More importantly, however, infrequent and short-duration TENS treatment is not optimal clinical practice. In most circumstances, it is recommended that TENS should be administered over the painful area or over peripheral nerves innervating the painful area. Evidence suggests that a strong, non-painful TENS sensation is a prerequisite for success and that maximal pain relief occurs during stimulation.[@b30-prom-5-035] Therefore, successful long-term users of TENS self-administer TENS treatment regularly throughout the day because pain may return within minutes once TENS has stopped.[@b31-prom-5-035] Unfortunately, the questionnaire did not include an item to gather information about why physiotherapists did not recommend that patients should self-administer TENS at home. One reason for this may be inappropriate beliefs about how best to administer TENS, perhaps resulting from inadequate undergraduate training. The small amount of training given on TENS and other electrotherapies in undergraduate training may contribute to the development of inappropriate beliefs about how best to administer treatment. Inappropriate beliefs that all electrotherapy treatments have to be supervised by a health care professional has been highlighted for interferential current therapy.[@b32-prom-5-035],[@b33-prom-5-035] Evidence suggests that patients can safely administer TENS themselves providing they are trained on safe and appropriate technique by a competent health care professional.[@b31-prom-5-035] Training protocols are readily available.[@b34-prom-5-035]

Another reason why respondents did not recommend that TENS should be used at home may be that patients (and clinics) are unable to afford to purchase their own TENS device, including ongoing costs of replacing batteries and electrodes. This may account for the finding that only 44% of respondents reported that they believed that TENS was a cost-effective modality. One strategy to overcome this challenge is for patients to purchase or rent a TENS device from clinics or manufacturers at a subsidized cost with the proviso that the device is returned when it is no longer needed. This is an advantage of TENS when compared with drug medication, as the TENS device can be reused and recycled for use by other patients once it is no longer needed. The ability to finance the purchase of a sufficient stock of TENS devices to loan to patients may be a challenge for many clinics. Negotiating discounts for bulk purchase from manufacturers and charity fundraising activities can be used to reduce costs to the clinic. Furthermore, TENS equipment is considerably more expensive in Sri Lanka costing approximately 20000 Sri Lankan Rupees, equivalent to 9245 Indian Rupees. Indian-made TENS devices are available for approximately 2000 Indian Rupees, equivalent to 4330 Sri Lankan Rupees. Importing cheaper, Indian-made TENS devices in bulk may be a solution. Deterioration of electrodes due to dusty environments resulting in the need for more frequent replacement of electrodes may also increase running costs.

Sociocultural acceptance of TENS as a viable treatment option may also be a potential barrier to widespread use, including difficulties in securing the TENS device to clothes because of the absence of a belt, for example, for women who wear "sarees". Nevertheless, the finding that nearly half of respondents reported that their patients had requested TENS treatment suggests that individuals with pain attending physiotherapy clinics are aware of TENS, despite limited advertisement of TENS through mainstream media.

Sri Lanka faces considerable challenges in delivering consistent and quality health care services across the nation.[@b21-prom-5-035],[@b22-prom-5-035] Pain management has been described as a fundamental human right that should be available in primary care settings,[@b34-prom-5-035],[@b36-prom-5-035] yet pain management services in Sri Lanka are not given priority.[@b35-prom-5-035],[@b36-prom-5-035] Most pain management services are confined to large hospitals, often in the private sector, and located in major cities such as Colombo and Kandy. Provision in public or government hospitals appears to be inadequate.[@b22-prom-5-035] This restricts pain management to people who can afford to pay for expensive treatments. TENS may be a cost-effective option for managing pain because it is a safe, inexpensive, and effective treatment that can be self-administered by the patient as needed and without fear of toxicity or overdose.

There were some methodological limitations to this study. The survey sample size was small and restricted to urban centers. Secondary health care services such as physiotherapy are scantily resourced in rural Sri Lanka, so we suspect that TENS may be used less often in rural areas. The views of the 33% of physiotherapists that did not respond to the questionnaire are not known, and it is possible that these non-respondents did not use TENS or had used TENS previously and found it to be ineffective. For these reasons, we express caution in generalizing the findings to the wider physiotherapy population in Sri Lanka and we plan to conduct a larger in-depth survey of all health professionals engaged with TENS in rural as well as urban Sri Lankan areas.

Conclusion
==========

Physiotherapists working in hospitals located in cities in Sri Lanka value TENS as a treatment option to manage musculoskeletal and neuropathic pain. They were less likely to use TENS for mild pain and for cancer pain. There appears to be a need for systems and resources to enable patients to self-administer TENS rather than having to visit clinics.
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###### 

Responses to questions related to types and severity of pain

  Pain types/conditions                                Respondents per response, n (%)                                         
  ---------------------------------------------------- --------------------------------- ------------ ------------ ----------- -----------
  Q3a: For which types of pain do you use TENS?                                                                                
  • Acute                                              16 (23.9)                         21 (31.3)    2 (3.0)      11 (16.4)   17 (25.4)
  • Subacute                                           6 (8.95)                          35 (52.2)    14 (20.9)    8 (11.9)    4 (6.0)
  • Chronic                                            9 (13.4)                          28 (41.8)    29 (43.3)    1 (1.5)     0 (0)
  Q3b: For which types of pain do you use TENS?                                                                                
  • Mild                                               6 (9.2)                           9 (13.85)    23 (35.4)    8 (12.3)    19 (29.2)
  • Mild to moderate                                   8 (12.3)                          8 (12.3)     25 (38.5)    19 (29.2)   5 (7.7)
  • Moderate                                           0 (0)                             24 (36.9)    23 (35.4)    12 (18.5)   6 (9.2)
  • Moderate to severe                                 10 (15.4)                         27 (41.5)    22 (33.85)   0 (0)       6 (9.2)
  • Severe                                             17 (26.15)                        29 (44.6)    11 (16.9)    0 (0)       8 (12.3)
  Q4: For which conditions do you commonly use TENS?                                                                           
  • Musculoskeletal/orthopedic                         21 (31.3)                         20 (29.85)   15 (22.4)    4 (6.0)     7 (10.45)
  • Neuropathy/neuralgia                               16 (23.9)                         37 (55.2)    7 (10.45)    3 (4.5)     4 (6.0)
  • Postsurgical                                       8 (11.9)                          6 (8.95)     26 (38.8)    16 (23.9)   11 (16.4)
  • Cancer pain                                        0 (0)                             1 (1.5)      4 (6.0)      15 (22.4)   47 (70.1)
  • Other pains (eg, dysmenorrhea)                     0 (0)                             0 (0)        10 (14.9)    22 (32.8)   35 (52.2)

**Note:** There were 67 respondents for all questions except Q3b, for which there were 65 respondents.

**Abbreviation:** TENS, transcutaneous electrical nerve stimulation.
